These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


307 related items for PubMed ID: 12203782

  • 1. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
    Arcellana-Panlilio MY, Egeler RM, Ujack E, Magliocco A, Stuart GC, Robbins SM, Coppes MJ.
    Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
    [Abstract] [Full Text] [Related]

  • 2. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 3. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J, Fried M.
    Oncogene; 2001 Nov 01; 20(50):7447-52. PubMed ID: 11704876
    [Abstract] [Full Text] [Related]

  • 4. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
    Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N.
    Cancer Res; 2001 Sep 01; 61(17):6335-9. PubMed ID: 11522621
    [Abstract] [Full Text] [Related]

  • 5. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug 01; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep 01; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 7. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G.
    Hepatology; 2002 Aug 01; 36(2):427-32. PubMed ID: 12143052
    [Abstract] [Full Text] [Related]

  • 8. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M, Xiong Y.
    Oncogene; 1996 Nov 07; 13(9):2033-8. PubMed ID: 8934552
    [Abstract] [Full Text] [Related]

  • 9. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
    Perrone F, Tabano S, Colombo F, Dagrada G, Birindelli S, Gronchi A, Colecchia M, Pierotti MA, Pilotti S.
    Clin Cancer Res; 2003 Sep 15; 9(11):4132-8. PubMed ID: 14519636
    [Abstract] [Full Text] [Related]

  • 10. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
    Kirsch M, Mörz M, Pinzer T, Schackert HK, Schackert G.
    Genes Chromosomes Cancer; 2009 Feb 15; 48(2):143-54. PubMed ID: 18973139
    [Abstract] [Full Text] [Related]

  • 11. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
    Grafström E, Egyházi S, Ringborg U, Hansson J, Platz A.
    Clin Cancer Res; 2005 Apr 15; 11(8):2991-7. PubMed ID: 15837753
    [Abstract] [Full Text] [Related]

  • 12. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
    Yuan C, Li J, Selby TL, Byeon IJ, Tsai MD.
    J Mol Biol; 1999 Nov 19; 294(1):201-11. PubMed ID: 10556039
    [Abstract] [Full Text] [Related]

  • 13. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of the INK4 family of genes in prostate carcinomas.
    Park DJ, Wilczynski SP, Pham EY, Miller CW, Koeffler HP.
    J Urol; 1997 May 08; 157(5):1995-9. PubMed ID: 9112579
    [Abstract] [Full Text] [Related]

  • 15. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O.
    IUBMB Life; 2004 Sep 08; 56(9):557-64. PubMed ID: 15590562
    [Abstract] [Full Text] [Related]

  • 16. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
    Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K.
    Pathol Int; 2004 Aug 08; 54(8):549-55. PubMed ID: 15260845
    [Abstract] [Full Text] [Related]

  • 17. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 08; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 18. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T.
    Hum Pathol; 2009 Jun 08; 40(6):817-26. PubMed ID: 19200577
    [Abstract] [Full Text] [Related]

  • 19. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M, Wu K, Fu M, Rao M, Albanese C, Russell RG, Lian H, Bregman D, White MA, Pestell RG.
    Cancer Res; 2004 Jun 15; 64(12):4122-30. PubMed ID: 15205322
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M, Oda Y.
    Clin Cancer Res; 2011 Jun 01; 17(11):3771-82. PubMed ID: 21262917
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.